ROCHE FINANCE LTD's Net Worth

$0

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is ROCHE FINANCE LTD

ROCHE FINANCE LTD does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Senseonics Holdings, Inc., Allakos Inc., Entrada Therapeutics, Inc., Foundation Medicine, Inc., Jasper Therapeutics, Inc., Pandion Therapeutics Holdco LLC, AILERON THERAPEUTICS INC, and Aligos Therapeutics, Inc..

SEC CIK

ROCHE FINANCE LTD's CIK is 0001053942

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Senseonics Holdings, Inc.

Investor
Updated Jun 07, 2017
Form 3
Jun 07, 2017
28.35M
Form 3
Mar 17, 2016
7.07M
Showing 2 results

Allakos Inc.

Investor
Updated Jul 23, 2018
Form 4
Jul 23, 2018
4.61M
Options
Jul 23
Form 3
Jul 18, 2018
Showing 2 results

Entrada Therapeutics, Inc.

Investor
Updated Nov 04, 2021
Form 4
Nov 04, 2021
2.81M
Options
Nov 02
Form 3
Oct 28, 2021
Showing 2 results

Foundation Medicine, Inc.

Investor
Updated Aug 02, 2018
Form 4
78.73%
16.22M
$137.00
$2.22B
Aug 02, 2018
37.24M
Purchase
Jul 31
Form 4
20.60M
$50.00
$1.03B
Apr 09, 2015
21.02M
Purchase
Apr 07
Form 3
Jan 21, 2015
414.82K
Showing 3 results

Jasper Therapeutics, Inc.

Investor
Updated Jan 26, 2023
Form 4
-1.62%
-75.00K
$1.89
-$141.75K
Jan 26, 2023
4.55M
Sale
Jan 25
Form 3
Oct 04, 2021
4.62M
Showing 2 results

Pandion Therapeutics, Inc.

Investor
Updated Jul 23, 2020
Form 4
-80.16%
-12.47M
$18.00
Jul 23, 2020
3.09M
Buy-Options
Jul 21
Form 3
Jul 16, 2020
Showing 2 results

AILERON THERAPEUTICS INC

Investor
Updated Jul 05, 2017
Form 4
-87.80%
-5.06M
$15.00
Jul 05, 2017
702.36K
Buy-Options
Jul 05
Form 3/A
Jul 05, 2017
3.87K
Form 3
Jun 28, 2017
Showing 3 results

Aligos Therapeutics, Inc.

Investor
Updated Nov 07, 2023
Form 3
Nov 07, 2023
11.03M
Showing 1 results